10x Genomics to Report Fourth Quarter and Full Year 2021 Financial Results on February 16, 2022
10x Genomics (Nasdaq: TXG) will release its fourth quarter and full year financial results for 2021 on February 16, 2022. A conference call is scheduled at 1:30 p.m. PT to discuss the results and future outlook. The company's integrated solutions for biological analysis have been widely adopted globally, with significant citations in research. 10x Genomics holds a robust patent portfolio exceeding 1,300 patents.
- Widely adopted products in top global research and pharmaceutical companies.
- Strong patent portfolio with over 1,300 patents.
- None.
PLEASANTON, Calif., Jan. 26, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2021 after market close on Wednesday, February 16, 2022. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the "Investors" section of the company website at www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend and have been cited in over 3,250 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,300 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Media:
media@10xgenomics.com
Investors:
investors@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2021-financial-results-on-february-16-2022-301469066.html
SOURCE 10x Genomics, Inc.
FAQ
When will 10x Genomics report its financial results for Q4 2021?
What time is the 10x Genomics conference call on February 16, 2022?
How can I access the webcast for the 10x Genomics financial results?
What is the significance of 10x Genomics' products in research?
